TD Asset Management Inc. reduced its position in shares of Teleflex Incorporated (NYSE:TFX) by 0.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 123,116 shares of the medical technology company’s stock after selling 834 shares during the period. TD Asset Management Inc.’s holdings in Teleflex were worth $25,579,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the stock. Asset Planning Services Ltd. bought a new stake in shares of Teleflex during the first quarter worth approximately $116,000. Livforsakringsbolaget Skandia Omsesidigt acquired a new position in shares of Teleflex during the first quarter valued at about $155,000. OLD Mutual Customised Solutions Proprietary Ltd. raised its position in shares of Teleflex by 200.0% in the first quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 900 shares of the medical technology company’s stock valued at $174,000 after buying an additional 600 shares in the last quarter. Campbell & CO Investment Adviser LLC acquired a new position in shares of Teleflex during the second quarter valued at about $200,000. Finally, Harvey Capital Management Inc. acquired a new position in shares of Teleflex during the second quarter valued at about $207,000. 93.02% of the stock is owned by institutional investors.

Teleflex Incorporated (TFX) opened at 205.34 on Friday. The firm has a market cap of $9.25 billion, a P/E ratio of 39.27 and a beta of 1.05. The firm’s 50-day moving average price is $209.41 and its 200-day moving average price is $196.91. Teleflex Incorporated has a 52-week low of $136.53 and a 52-week high of $217.97.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, August 3rd. The medical technology company reported $2.04 EPS for the quarter, beating the Zacks’ consensus estimate of $1.91 by $0.13. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. The firm had revenue of $528.60 million during the quarter, compared to analysts’ expectations of $518.98 million. During the same quarter last year, the firm posted $1.89 earnings per share. The company’s revenue for the quarter was up 11.6% compared to the same quarter last year. Equities research analysts expect that Teleflex Incorporated will post $8.28 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 15th. Shareholders of record on Tuesday, August 15th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Friday, August 11th. This represents a $1.36 dividend on an annualized basis and a yield of 0.66%. Teleflex’s dividend payout ratio (DPR) is presently 26.00%.

TRADEMARK VIOLATION WARNING: This piece of content was posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://theolympiareport.com/2017/08/12/teleflex-incorporated-nysetfx-position-decreased-by-td-asset-management-inc.html.

A number of research firms have weighed in on TFX. Deutsche Bank AG reaffirmed a “buy” rating and set a $238.00 price target (up previously from $220.00) on shares of Teleflex in a research report on Wednesday. Jefferies Group LLC reaffirmed a “buy” rating and set a $253.00 price target (up previously from $230.00) on shares of Teleflex in a research report on Wednesday. BidaskClub downgraded Teleflex from a “hold” rating to a “sell” rating in a research report on Tuesday. Needham & Company LLC reaffirmed a “buy” rating on shares of Teleflex in a research report on Friday, August 4th. Finally, Barclays PLC reaffirmed a “buy” rating on shares of Teleflex in a research report on Monday, June 26th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and six have issued a buy rating to the company’s stock. Teleflex currently has an average rating of “Buy” and a consensus price target of $228.00.

In other Teleflex news, Director Stuart A. Randle sold 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $205.67, for a total value of $514,175.00. Following the completion of the sale, the director now owns 7,532 shares of the company’s stock, valued at $1,549,106.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Stephen K. M.D. Klasko sold 200 shares of the firm’s stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $199.93, for a total value of $39,986.00. Following the completion of the sale, the director now directly owns 8,080 shares of the company’s stock, valued at approximately $1,615,434.40. The disclosure for this sale can be found here. Insiders sold 8,300 shares of company stock valued at $1,643,975 in the last three months. Insiders own 2.39% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.